Utama › Degenerasi Makula
Kajian klinikal Degenerasi Makula sedang mengambil peserta di AS
55 kajian untuk Degenerasi Makula sedang mengambil peserta di lokasi seluruh Amerika Syarikat.
Bandar dengan paling banyak kajian
- Dallas, TX13 kajian
- Erie, PA10 kajian
- The Woodlands, TX9 kajian
- Sacramento, CA8 kajian
- Hagerstown, MD8 kajian
- Reno, NV8 kajian
- Phoenix, AZ7 kajian
- Cleveland, OH7 kajian
- Houston, TX7 kajian
- Salt Lake City, UT7 kajian
- Boston, MA7 kajian
- Austin, TX7 kajian
- Carmel, IN7 kajian
- Fort Worth, TX7 kajian
- Santa Monica, CA7 kajian
- Washington, DC6 kajian
- Cincinnati, OH6 kajian
- McAllen, TX6 kajian
- Philadelphia, PA6 kajian
- Mountain View, CA6 kajian
- Portland, OR6 kajian
- Columbia, SC6 kajian
- Nashville, TN6 kajian
- Raleigh, NC6 kajian
- Naperville, IL6 kajian
- Durham, NC5 kajian
- Pensacola, FL5 kajian
- Spokane, WA5 kajian
- Eugene, OR5 kajian
- Tampa, FL5 kajian
- Fort Lauderdale, FL5 kajian
- Lynchburg, VA5 kajian
- Orlando, FL5 kajian
- San Francisco, CA5 kajian
- Syracuse, NY5 kajian
- San Antonio, TX5 kajian
- Sarasota, FL4 kajian
- Jacksonville, FL4 kajian
- Ann Arbor, MI4 kajian
- Memphis, TN4 kajian
Mengikut negeri
- Arizona11 kajian
- California20 kajian
- Colorado7 kajian
- Connecticut6 kajian
- Florida14 kajian
- Georgia6 kajian
- Illinois13 kajian
- Indiana7 kajian
- Maryland11 kajian
- Massachusetts14 kajian
- Michigan9 kajian
- Minnesota5 kajian
- Mississippi5 kajian
- Missouri5 kajian
- Nevada8 kajian
- New Jersey7 kajian
- New York10 kajian
- North Carolina11 kajian
- Ohio11 kajian
- Oklahoma3 kajian
- Oregon9 kajian
- Pennsylvania17 kajian
- South Carolina8 kajian
- Tennessee7 kajian
- Texas24 kajian
- Utah9 kajian
- Virginia7 kajian
- Washington8 kajian
- Wisconsin6 kajian
Kajian yang dikemas kini baru-baru ini
Teks kajian rasmi (Bahasa Inggeris)
National Eye Institute Biorepository for Retinal Diseases
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 2 hingga 120 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT01496625A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
Mengambil pesertaFasa 2/3
Umur 50 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT07440225A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
Mengambil pesertaFasa 2/3
Umur 60 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT06635148A Phase 1/2 Study of the Safety and Efficacy of BRX011 Oral Administration Once Daily in Subjects With Geographic Atrophy Secondary to Age-Related Macular Degeneration
Mengambil pesertaFasa 1/2
Umur 55 ke atas · Semua jantina · Dikemas kini 23 Sep 2026 · NCT07029945Cell Collection to Study Eye Diseases
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
1 Day – 120 Years · Semua jantina · Dikemas kini 22 Sep 2026 · NCT01432847A Study in Adults With Geographic Atrophy
Mengambil pesertaFasa 2
Umur 60 ke atas · Semua jantina · Dikemas kini 21 Sep 2026 · NCT07606365A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
Mengambil pesertaFasa 3
Umur 50 hingga 85 · Semua jantina · Dikemas kini 18 Sep 2026 · NCT06541704A Study About the Safety of a Single ASP2020 Eye Injection and if it Helps People With Vision Loss From Stargardt-type Eye Conditions
Mengambil pesertaFasa 1
Umur 6 ke atas · Semua jantina · Dikemas kini 16 Sep 2026 · NCT07734064The Effects of Disulfiram (Antabuse®) on Visual Acuity in Patients With Retinal Degeneration
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 16 Sep 2026 · NCT06319872A Phase 2 Study of NT-101 Topical in Patients With Wet AMD
Mengambil pesertaFasa 2
Umur 50 ke atas · Semua jantina · Dikemas kini 16 Sep 2026 · NCT07811726Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
Mengambil pesertaFasa 2
Umur 55 ke atas · Semua jantina · Dikemas kini 10 Sep 2026 · NCT06659445Noninvasive Imaging Biomarkers of Treatable Macrovascular Disease in Age-related Macular Degeneration.
Mengambil pesertaKajian pemerhatian
Umur 50 hingga 80 · Semua jantina · Dikemas kini 3 Sep 2026 · NCT07798323A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
Mengambil pesertaFasa 1
Umur 50 ke atas · Semua jantina · Dikemas kini 3 Sep 2026 · NCT03178149A Non-Interventional Study Observing Short-Term Progression in Geographic Atrophy (GA)
Mengambil pesertaKajian pemerhatian
Umur 55 ke atas · Semua jantina · Dikemas kini 3 Sep 2026 · NCT07144137Effect of Lutein, Zeaxanthin, and Meso-Zeaxanthin Supplementation on Skin Carotenoid Concentration: A Six-Month, Placebo-Controlled Crossover Study
Mengambil pesertaSukarelawan sihat dialu-alukan
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Sep 2026 · NCT06965426A Long-term Follow-up Study to Evaluate SKG0106 in the Treatment of Patients With nAMD
Mengambil pesertaKajian pemerhatian
Umur 50 ke atas · Semua jantina · Dikemas kini 1 Sep 2026 · NCT06346600SGLT2 Inhibitors in Geographic Atrophy
Mengambil pesertaFasa 2
Umur 50 ke atas · Semua jantina · Dikemas kini 26 Ogo 2026 · NCT07174687Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration
Mengambil peserta
Umur 60 ke atas · Semua jantina · Dikemas kini 26 Ogo 2026 · NCT06662162A Study to Learn How Stargardt-type Eye Conditions Progress in Children and Adults
Mengambil pesertaKajian pemerhatian
Umur 6 ke atas · Semua jantina · Dikemas kini 25 Ogo 2026 · NCT074255744D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration
Mengambil pesertaFasa 1/2
Umur 50 ke atas · Semua jantina · Dikemas kini 21 Ogo 2026 · NCT05197270A Phase 2 Efficacy and Safety Study of GAL-101, 2% Ophthalmic Solution in Non-foveal Geographic Atrophy Secondary to Non-neovascular AMD
Mengambil pesertaFasa 2
Umur 55 ke atas · Semua jantina · Dikemas kini 20 Ogo 2026 · NCT06659549Phase 1 Study of C.001 in Retinal Degeneration
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Ogo 2026 · NCT07594236AMD and Validation Rod-Meditated Dark Adaptation With Everyday Task Performance
Mengambil pesertaSukarelawan sihat dialu-alukan
Umur 50 hingga 89 · Semua jantina · Dikemas kini 10 Ogo 2026 · NCT06619405A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)
Mengambil pesertaFasa 2/3
Umur 50 ke atas · Semua jantina · Dikemas kini 6 Ogo 2026 · NCT07496567Intravitreal (IVT) Pozelimab for Geographic Atrophy (GA) in Adult Participants
Mengambil pesertaFasa 1
Umur 50 ke atas · Semua jantina · Dikemas kini 5 Ogo 2026 · NCT07230834Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.